

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.66267996 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.66267996 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.31693886 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.31693886 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.72887644 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.48523055 |
| 7 | exogenous drug catabolic process (GO:0042738) | 6.46911774 |
| 8 | epoxygenase P450 pathway (GO:0019373) | 6.05131267 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.91371644 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.91371644 |
| 11 | tryptophan catabolic process (GO:0006569) | 5.91371644 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.82744782 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.77473741 |
| 14 | high-density lipoprotein particle remodeling (GO:0034375) | 5.70651300 |
| 15 | negative regulation of fibrinolysis (GO:0051918) | 5.69051719 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.66925373 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.59567788 |
| 18 | omega-hydroxylase P450 pathway (GO:0097267) | 5.54892296 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 5.53429901 |
| 20 | urea cycle (GO:0000050) | 5.52200984 |
| 21 | urea metabolic process (GO:0019627) | 5.52200984 |
| 22 | regulation of fibrinolysis (GO:0051917) | 5.44652383 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 5.35783567 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.35479242 |
| 25 | protein carboxylation (GO:0018214) | 5.35479242 |
| 26 | cysteine metabolic process (GO:0006534) | 5.25723440 |
| 27 | complement activation, alternative pathway (GO:0006957) | 5.25080757 |
| 28 | regulation of protein activation cascade (GO:2000257) | 5.22256846 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 5.08274155 |
| 30 | reverse cholesterol transport (GO:0043691) | 5.05729564 |
| 31 | serine family amino acid catabolic process (GO:0009071) | 5.01631803 |
| 32 | regulation of cholesterol esterification (GO:0010872) | 5.00631541 |
| 33 | bile acid metabolic process (GO:0008206) | 4.97269937 |
| 34 | regulation of triglyceride catabolic process (GO:0010896) | 4.91987176 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 4.88661715 |
| 36 | plasma lipoprotein particle remodeling (GO:0034369) | 4.87798691 |
| 37 | protein-lipid complex remodeling (GO:0034368) | 4.87798691 |
| 38 | macromolecular complex remodeling (GO:0034367) | 4.87798691 |
| 39 | regulation of complement activation (GO:0030449) | 4.87517363 |
| 40 | tyrosine metabolic process (GO:0006570) | 4.83527106 |
| 41 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.77866486 |
| 42 | triglyceride homeostasis (GO:0070328) | 4.75006514 |
| 43 | acylglycerol homeostasis (GO:0055090) | 4.75006514 |
| 44 | drug metabolic process (GO:0017144) | 4.73190393 |
| 45 | phospholipid efflux (GO:0033700) | 4.72118350 |
| 46 | phenylpropanoid metabolic process (GO:0009698) | 4.62625830 |
| 47 | intestinal cholesterol absorption (GO:0030299) | 4.60988021 |
| 48 | homocysteine metabolic process (GO:0050667) | 4.57217394 |
| 49 | alpha-amino acid catabolic process (GO:1901606) | 4.55150065 |
| 50 | plasma lipoprotein particle clearance (GO:0034381) | 4.53977849 |
| 51 | negative regulation of cholesterol transport (GO:0032375) | 4.52998124 |
| 52 | negative regulation of sterol transport (GO:0032372) | 4.52998124 |
| 53 | amino-acid betaine metabolic process (GO:0006577) | 4.52969712 |
| 54 | lysine catabolic process (GO:0006554) | 4.48528772 |
| 55 | lysine metabolic process (GO:0006553) | 4.48528772 |
| 56 | cellular ketone body metabolic process (GO:0046950) | 4.42957137 |
| 57 | ethanol metabolic process (GO:0006067) | 4.41547840 |
| 58 | negative regulation of hemostasis (GO:1900047) | 4.40021172 |
| 59 | negative regulation of blood coagulation (GO:0030195) | 4.40021172 |
| 60 | oxidative demethylation (GO:0070989) | 4.34513324 |
| 61 | cholesterol efflux (GO:0033344) | 4.29328947 |
| 62 | coenzyme catabolic process (GO:0009109) | 4.25979813 |
| 63 | bile acid and bile salt transport (GO:0015721) | 4.25299233 |
| 64 | acute-phase response (GO:0006953) | 4.24896020 |
| 65 | glycine metabolic process (GO:0006544) | 4.24447311 |
| 66 | indolalkylamine metabolic process (GO:0006586) | 4.21770391 |
| 67 | cellular amino acid catabolic process (GO:0009063) | 4.19718987 |
| 68 | imidazole-containing compound metabolic process (GO:0052803) | 4.19351995 |
| 69 | negative regulation of protein activation cascade (GO:2000258) | 4.16306355 |
| 70 | glutamate metabolic process (GO:0006536) | 4.13765643 |
| 71 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.13516310 |
| 72 | cellular biogenic amine catabolic process (GO:0042402) | 4.10732839 |
| 73 | amine catabolic process (GO:0009310) | 4.10732839 |
| 74 | plasma lipoprotein particle assembly (GO:0034377) | 4.10155272 |
| 75 | cellular glucuronidation (GO:0052695) | 4.05819162 |
| 76 | serine family amino acid metabolic process (GO:0009069) | 4.04234394 |
| 77 | negative regulation of coagulation (GO:0050819) | 4.03809150 |
| 78 | fibrinolysis (GO:0042730) | 4.01230927 |
| 79 | benzene-containing compound metabolic process (GO:0042537) | 3.97645230 |
| 80 | negative regulation of wound healing (GO:0061045) | 3.96810697 |
| 81 | cellular modified amino acid catabolic process (GO:0042219) | 3.95386737 |
| 82 | aldehyde catabolic process (GO:0046185) | 3.95270084 |
| 83 | arginine metabolic process (GO:0006525) | 3.93315568 |
| 84 | low-density lipoprotein particle remodeling (GO:0034374) | 3.92798405 |
| 85 | protein-lipid complex subunit organization (GO:0071825) | 3.90802446 |
| 86 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.90038607 |
| 87 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.90038607 |
| 88 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.89821988 |
| 89 | ethanol oxidation (GO:0006069) | 3.88744150 |
| 90 | negative regulation of lipase activity (GO:0060192) | 3.84658209 |
| 91 | blood coagulation, intrinsic pathway (GO:0007597) | 3.83414022 |
| 92 | ketone body metabolic process (GO:1902224) | 3.83085536 |
| 93 | drug catabolic process (GO:0042737) | 3.82385330 |
| 94 | serine family amino acid biosynthetic process (GO:0009070) | 3.82092283 |
| 95 | positive regulation of lipid catabolic process (GO:0050996) | 3.79649416 |
| 96 | positive regulation of hemostasis (GO:1900048) | 3.79301948 |
| 97 | positive regulation of blood coagulation (GO:0030194) | 3.79301948 |
| 98 | regulation of humoral immune response (GO:0002920) | 3.79296670 |
| 99 | acylglycerol catabolic process (GO:0046464) | 3.77617717 |
| 100 | neutral lipid catabolic process (GO:0046461) | 3.77617717 |
| 101 | phospholipid homeostasis (GO:0055091) | 3.75387204 |
| 102 | cholesterol homeostasis (GO:0042632) | 3.75359370 |
| 103 | cofactor catabolic process (GO:0051187) | 3.74567272 |
| 104 | polyketide metabolic process (GO:0030638) | 3.73461379 |
| 105 | doxorubicin metabolic process (GO:0044598) | 3.73461379 |
| 106 | daunorubicin metabolic process (GO:0044597) | 3.73461379 |
| 107 | plasma lipoprotein particle organization (GO:0071827) | 3.72069839 |
| 108 | organic acid catabolic process (GO:0016054) | 3.70398860 |
| 109 | carboxylic acid catabolic process (GO:0046395) | 3.70398860 |
| 110 | sterol homeostasis (GO:0055092) | 3.69269918 |
| 111 | complement activation, classical pathway (GO:0006958) | 3.68810314 |
| 112 | protein-lipid complex assembly (GO:0065005) | 3.67200852 |
| 113 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.67192911 |
| 114 | regulation of bile acid biosynthetic process (GO:0070857) | 3.65407648 |
| 115 | protein activation cascade (GO:0072376) | 3.65199045 |
| 116 | complement activation (GO:0006956) | 3.64538660 |
| 117 | regulation of cholesterol homeostasis (GO:2000188) | 3.63982539 |
| 118 | cytolysis (GO:0019835) | 3.61644522 |
| 119 | uronic acid metabolic process (GO:0006063) | 3.61196058 |
| 120 | glucuronate metabolic process (GO:0019585) | 3.61196058 |
| 121 | triglyceride catabolic process (GO:0019433) | 3.60395154 |
| 122 | short-chain fatty acid metabolic process (GO:0046459) | 3.60347799 |
| 123 | regulation of lipoprotein particle clearance (GO:0010984) | 3.58229316 |
| 124 | acetyl-CoA metabolic process (GO:0006084) | 3.56950376 |
| 125 | lipoprotein metabolic process (GO:0042157) | 3.53489808 |
| 126 | positive regulation of coagulation (GO:0050820) | 3.50890035 |
| 127 | regulation of plasminogen activation (GO:0010755) | 3.50582493 |
| 128 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.48134687 |
| 129 | S-adenosylmethionine metabolic process (GO:0046500) | 3.46038533 |
| 130 | regulation of sterol transport (GO:0032371) | 3.36889187 |
| 131 | regulation of cholesterol transport (GO:0032374) | 3.36889187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.34097958 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.13530643 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.84926916 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.46900457 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.28320779 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.14740744 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.06644543 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.99249470 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.98917881 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.11036374 |
| 11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06565097 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.03994233 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8717636 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.72392824 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 1.66576376 |
| 16 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61140092 |
| 17 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.52106107 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.48246669 |
| 19 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.46545276 |
| 20 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39588778 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29712262 |
| 22 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19965556 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18338558 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.15247802 |
| 25 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09529306 |
| 26 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.06039673 |
| 27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.02874623 |
| 28 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.02627585 |
| 29 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.01606847 |
| 30 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.96888449 |
| 31 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.93225303 |
| 32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.86468764 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.85539736 |
| 34 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.84397413 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.81969588 |
| 36 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81563943 |
| 37 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.81533112 |
| 38 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.80601235 |
| 39 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.80426593 |
| 40 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79847335 |
| 41 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79408558 |
| 42 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.78817586 |
| 43 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.78548967 |
| 44 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76402117 |
| 45 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.75944855 |
| 46 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74685842 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.73873830 |
| 48 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72954954 |
| 49 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71550616 |
| 50 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69882264 |
| 51 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.69871647 |
| 52 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69414627 |
| 53 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.68794362 |
| 54 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.68705611 |
| 55 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.65615682 |
| 56 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.63806134 |
| 57 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.63574607 |
| 58 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.63574607 |
| 59 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.63137151 |
| 60 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.62961767 |
| 61 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.62661130 |
| 62 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61783722 |
| 63 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.61691519 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.61020153 |
| 65 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.60891562 |
| 66 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.60029807 |
| 67 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.59497071 |
| 68 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.59032411 |
| 69 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.59012593 |
| 70 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.58946922 |
| 71 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.58563917 |
| 72 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.58488169 |
| 73 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.58307959 |
| 74 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.58151796 |
| 75 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.56945573 |
| 76 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.56887229 |
| 77 | AR_20517297_ChIP-Seq_VCAP_Human | 0.56452522 |
| 78 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.56112865 |
| 79 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.55925171 |
| 80 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.55022564 |
| 81 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.54619232 |
| 82 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.54413468 |
| 83 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.53575825 |
| 84 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.53471267 |
| 85 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.53405224 |
| 86 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.51754750 |
| 87 | GATA1_19941826_ChIP-Seq_K562_Human | 0.51441915 |
| 88 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.51235879 |
| 89 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.50640579 |
| 90 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.50400842 |
| 91 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.50335792 |
| 92 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50232035 |
| 93 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.48891981 |
| 94 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.48067925 |
| 95 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47946812 |
| 96 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.47799062 |
| 97 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.47742849 |
| 98 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.46778500 |
| 99 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.46579162 |
| 100 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.46467653 |
| 101 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.46390096 |
| 102 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.46204832 |
| 103 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.46021652 |
| 104 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.45600416 |
| 105 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.45026813 |
| 106 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.44425929 |
| 107 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.43804062 |
| 108 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.43154396 |
| 109 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.43127020 |
| 110 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.42648695 |
| 111 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.41667277 |
| 112 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41485300 |
| 113 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41145142 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 0.40910371 |
| 115 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.40142406 |
| 116 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38222299 |
| 117 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37269798 |
| 118 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.36639731 |
| 119 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.36443919 |
| 120 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.36215733 |
| 121 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.36062266 |
| 122 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.35982507 |
| 123 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.35760540 |
| 124 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.35690098 |
| 125 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.35578158 |
| 126 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35394645 |
| 127 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.35164774 |
| 128 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.35099422 |
| 129 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.35039040 |
| 130 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.34686571 |
| 131 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.34422407 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.17418472 |
| 2 | MP0005360_urolithiasis | 7.32103026 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.28567197 |
| 4 | MP0005365_abnormal_bile_salt | 6.25395002 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.04431358 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.13514051 |
| 7 | MP0003252_abnormal_bile_duct | 3.87900875 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.66620572 |
| 9 | MP0009840_abnormal_foam_cell | 3.37086020 |
| 10 | MP0003195_calcinosis | 3.11113292 |
| 11 | MP0005083_abnormal_biliary_tract | 3.01950492 |
| 12 | MP0005332_abnormal_amino_acid | 2.77446031 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.59175307 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.41979623 |
| 15 | MP0000609_abnormal_liver_physiology | 2.18790380 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.16505080 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.06825174 |
| 18 | MP0003868_abnormal_feces_composition | 1.94140488 |
| 19 | * MP0004019_abnormal_vitamin_homeostasis | 1.92671276 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.82412062 |
| 21 | MP0001764_abnormal_homeostasis | 1.75958295 |
| 22 | MP0009697_abnormal_copulation | 1.56407297 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55447739 |
| 24 | MP0005451_abnormal_body_composition | 1.37676257 |
| 25 | MP0003011_delayed_dark_adaptation | 1.37343162 |
| 26 | MP0009643_abnormal_urine_homeostasis | 1.32135367 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.30698049 |
| 28 | MP0003186_abnormal_redox_activity | 1.26042409 |
| 29 | MP0000598_abnormal_liver_morphology | 1.18855031 |
| 30 | MP0003879_abnormal_hair_cell | 1.15959812 |
| 31 | MP0002132_abnormal_respiratory_system | 1.10390571 |
| 32 | MP0000604_amyloidosis | 1.08977013 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.08833684 |
| 34 | MP0005647_abnormal_sex_gland | 1.04980829 |
| 35 | MP0002909_abnormal_adrenal_gland | 1.04573705 |
| 36 | MP0005636_abnormal_mineral_homeostasis | 1.02817972 |
| 37 | MP0005084_abnormal_gallbladder_morpholo | 1.02672318 |
| 38 | MP0003122_maternal_imprinting | 1.01120182 |
| 39 | MP0010368_abnormal_lymphatic_system | 0.99101473 |
| 40 | MP0009763_increased_sensitivity_to | 0.98021097 |
| 41 | MP0002078_abnormal_glucose_homeostasis | 0.97231128 |
| 42 | MP0002254_reproductive_system_inflammat | 0.96566556 |
| 43 | MP0009764_decreased_sensitivity_to | 0.96016830 |
| 44 | MP0005670_abnormal_white_adipose | 0.95629338 |
| 45 | MP0005220_abnormal_exocrine_pancreas | 0.95587799 |
| 46 | MP0009642_abnormal_blood_homeostasis | 0.91076361 |
| 47 | MP0005408_hypopigmentation | 0.90977275 |
| 48 | MP0008469_abnormal_protein_level | 0.87842951 |
| 49 | MP0006036_abnormal_mitochondrial_physio | 0.87664909 |
| 50 | MP0002876_abnormal_thyroid_physiology | 0.86147367 |
| 51 | MP0002971_abnormal_brown_adipose | 0.80693278 |
| 52 | MP0005376_homeostasis/metabolism_phenot | 0.80303301 |
| 53 | MP0004130_abnormal_muscle_cell | 0.77871359 |
| 54 | MP0005334_abnormal_fat_pad | 0.77724347 |
| 55 | MP0000003_abnormal_adipose_tissue | 0.76525364 |
| 56 | MP0001756_abnormal_urination | 0.76354136 |
| 57 | MP0009780_abnormal_chondrocyte_physiolo | 0.75516990 |
| 58 | MP0002837_dystrophic_cardiac_calcinosis | 0.75336920 |
| 59 | MP0005535_abnormal_body_temperature | 0.73974354 |
| 60 | MP0001915_intracranial_hemorrhage | 0.73420597 |
| 61 | MP0009765_abnormal_xenobiotic_induced | 0.72826989 |
| 62 | MP0003172_abnormal_lysosome_physiology | 0.71567704 |
| 63 | MP0001661_extended_life_span | 0.71148571 |
| 64 | MP0000639_abnormal_adrenal_gland | 0.70197020 |
| 65 | MP0005164_abnormal_response_to | 0.63967530 |
| 66 | MP0005448_abnormal_energy_balance | 0.63830611 |
| 67 | MP0003329_amyloid_beta_deposits | 0.63675725 |
| 68 | MP0005266_abnormal_metabolism | 0.62991433 |
| 69 | MP0003690_abnormal_glial_cell | 0.62984725 |
| 70 | MP0009053_abnormal_anal_canal | 0.58526134 |
| 71 | MP0002928_abnormal_bile_duct | 0.57433839 |
| 72 | MP0003283_abnormal_digestive_organ | 0.56503182 |
| 73 | MP0005187_abnormal_penis_morphology | 0.56044576 |
| 74 | MP0004272_abnormal_basement_membrane | 0.53685127 |
| 75 | MP0003953_abnormal_hormone_level | 0.52759161 |
| 76 | MP0006035_abnormal_mitochondrial_morpho | 0.50004519 |
| 77 | MP0005464_abnormal_platelet_physiology | 0.49640193 |
| 78 | MP0005452_abnormal_adipose_tissue | 0.49346130 |
| 79 | MP0000566_synostosis | 0.49342011 |
| 80 | MP0003638_abnormal_response/metabolism_ | 0.48360384 |
| 81 | MP0005666_abnormal_adipose_tissue | 0.47731812 |
| 82 | MP0001944_abnormal_pancreas_morphology | 0.47325774 |
| 83 | MP0002136_abnormal_kidney_physiology | 0.46991450 |
| 84 | MP0002822_catalepsy | 0.46719342 |
| 85 | MP0005395_other_phenotype | 0.46474419 |
| 86 | MP0002089_abnormal_postnatal_growth/wei | 0.44823996 |
| 87 | MP0004782_abnormal_surfactant_physiolog | 0.44662887 |
| 88 | MP0009672_abnormal_birth_weight | 0.44287098 |
| 89 | MP0003724_increased_susceptibility_to | 0.42665248 |
| 90 | MP0004264_abnormal_extraembryonic_tissu | 0.40659983 |
| 91 | MP0002970_abnormal_white_adipose | 0.40517900 |
| 92 | MP0008873_increased_physiological_sensi | 0.40020720 |
| 93 | MP0008874_decreased_physiological_sensi | 0.39661834 |
| 94 | MP0003959_abnormal_lean_body | 0.38895315 |
| 95 | MP0001986_abnormal_taste_sensitivity | 0.38867226 |
| 96 | MP0004185_abnormal_adipocyte_glucose | 0.38571724 |
| 97 | MP0000013_abnormal_adipose_tissue | 0.38441882 |
| 98 | MP0000230_abnormal_systemic_arterial | 0.37969972 |
| 99 | MP0005023_abnormal_wound_healing | 0.37783023 |
| 100 | MP0005167_abnormal_blood-brain_barrier | 0.37655975 |
| 101 | MP0009115_abnormal_fat_cell | 0.37654208 |
| 102 | MP0005058_abnormal_lysosome_morphology | 0.35830969 |
| 103 | MP0003436_decreased_susceptibility_to | 0.35547707 |
| 104 | MP0003075_altered_response_to | 0.35295673 |
| 105 | MP0003718_maternal_effect | 0.34860618 |
| 106 | MP0003633_abnormal_nervous_system | 0.34824467 |
| 107 | MP0002168_other_aberrant_phenotype | 0.34471232 |
| 108 | MP0008872_abnormal_physiological_respon | 0.33820241 |
| 109 | MP0001243_abnormal_dermal_layer | 0.33394073 |
| 110 | MP0005248_abnormal_Harderian_gland | 0.33370437 |
| 111 | MP0000249_abnormal_blood_vessel | 0.31738588 |
| 112 | MP0002796_impaired_skin_barrier | 0.30784742 |
| 113 | MP0004883_abnormal_blood_vessel | 0.30703938 |
| 114 | MP0004043_abnormal_pH_regulation | 0.30470300 |
| 115 | MP0002693_abnormal_pancreas_physiology | 0.30337048 |
| 116 | MP0005166_decreased_susceptibility_to | 0.30248662 |
| 117 | MP0001881_abnormal_mammary_gland | 0.29220064 |
| 118 | MP0003123_paternal_imprinting | 0.29176869 |
| 119 | MP0005379_endocrine/exocrine_gland_phen | 0.28155135 |
| 120 | MP0005375_adipose_tissue_phenotype | 0.27336446 |
| 121 | MP0001845_abnormal_inflammatory_respons | 0.26791416 |
| 122 | MP0002060_abnormal_skin_morphology | 0.26292225 |
| 123 | MP0005377_hearing/vestibular/ear_phenot | 0.26109027 |
| 124 | MP0003878_abnormal_ear_physiology | 0.26109027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.62788904 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.25244864 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.00555025 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.48824364 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.42667842 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.25261910 |
| 7 | Xanthomatosis (HP:0000991) | 6.20517940 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.54633801 |
| 9 | Complement deficiency (HP:0004431) | 5.24118996 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.75990371 |
| 11 | Joint hemorrhage (HP:0005261) | 4.72569315 |
| 12 | Hyperammonemia (HP:0001987) | 4.52466814 |
| 13 | Hypoglycemic coma (HP:0001325) | 4.46241528 |
| 14 | Ketosis (HP:0001946) | 4.45385246 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.42733630 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.35598454 |
| 17 | Epidermoid cyst (HP:0200040) | 4.32121712 |
| 18 | Hyperglycinemia (HP:0002154) | 4.31542853 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 4.23793544 |
| 20 | Abnormality of methionine metabolism (HP:0010901) | 4.13388664 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.10006667 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.96222624 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.95580337 |
| 24 | Fat malabsorption (HP:0002630) | 3.93130075 |
| 25 | Hyperglycinuria (HP:0003108) | 3.87323601 |
| 26 | Abnormality of the intrinsic pathway (HP:0010989) | 3.86651987 |
| 27 | Abnormality of complement system (HP:0005339) | 3.82738921 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.82016301 |
| 29 | Abnormality of glycine metabolism (HP:0010895) | 3.82016301 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.65996243 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.64224698 |
| 32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.55750834 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.55715832 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.45275725 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.38523875 |
| 36 | Ketoacidosis (HP:0001993) | 3.35502715 |
| 37 | Hypoglycemic seizures (HP:0002173) | 3.09595055 |
| 38 | Nephritis (HP:0000123) | 3.07498597 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.00006301 |
| 40 | Delayed CNS myelination (HP:0002188) | 2.96570163 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 2.95697107 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 2.94449099 |
| 43 | Steatorrhea (HP:0002570) | 2.91716432 |
| 44 | Spontaneous abortion (HP:0005268) | 2.89621532 |
| 45 | Hypochromic microcytic anemia (HP:0004840) | 2.87721829 |
| 46 | Skin nodule (HP:0200036) | 2.81240171 |
| 47 | Myocardial infarction (HP:0001658) | 2.79318355 |
| 48 | Metabolic acidosis (HP:0001942) | 2.78902293 |
| 49 | Systemic lupus erythematosus (HP:0002725) | 2.72198703 |
| 50 | Abnormality of purine metabolism (HP:0004352) | 2.67011330 |
| 51 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.65725402 |
| 52 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.61860803 |
| 53 | Dicarboxylic aciduria (HP:0003215) | 2.61860803 |
| 54 | Lethargy (HP:0001254) | 2.58168167 |
| 55 | Abnormal gallbladder morphology (HP:0012437) | 2.55545994 |
| 56 | Late onset (HP:0003584) | 2.55047886 |
| 57 | Gout (HP:0001997) | 2.52778721 |
| 58 | Acanthocytosis (HP:0001927) | 2.48554429 |
| 59 | Mitral stenosis (HP:0001718) | 2.45659463 |
| 60 | Irritability (HP:0000737) | 2.42347770 |
| 61 | Cholecystitis (HP:0001082) | 2.41973928 |
| 62 | Abnormal gallbladder physiology (HP:0012438) | 2.41973928 |
| 63 | Cholelithiasis (HP:0001081) | 2.41109347 |
| 64 | Purpura (HP:0000979) | 2.40129038 |
| 65 | Vascular calcification (HP:0004934) | 2.39638491 |
| 66 | Glomerulonephritis (HP:0000099) | 2.37606680 |
| 67 | Cerebral edema (HP:0002181) | 2.37314761 |
| 68 | Hyperglycemia (HP:0003074) | 2.33756633 |
| 69 | Amyloidosis (HP:0011034) | 2.33212502 |
| 70 | Enlarged kidneys (HP:0000105) | 2.31328302 |
| 71 | Spastic diplegia (HP:0001264) | 2.28273609 |
| 72 | Arthropathy (HP:0003040) | 2.28209086 |
| 73 | Neonatal onset (HP:0003623) | 2.27636232 |
| 74 | Osteomalacia (HP:0002749) | 2.27217831 |
| 75 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.25817973 |
| 76 | Brushfield spots (HP:0001088) | 2.25289837 |
| 77 | Generalized aminoaciduria (HP:0002909) | 2.25103185 |
| 78 | Pancreatitis (HP:0001733) | 2.19236451 |
| 79 | Hyperphosphaturia (HP:0003109) | 2.18932738 |
| 80 | Esophageal varix (HP:0002040) | 2.18061381 |
| 81 | Symptomatic seizures (HP:0011145) | 2.16497597 |
| 82 | Sensorimotor neuropathy (HP:0007141) | 2.15582397 |
| 83 | Glycosuria (HP:0003076) | 2.13281860 |
| 84 | Abnormality of urine glucose concentration (HP:0011016) | 2.13281860 |
| 85 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.12316326 |
| 86 | Cardiovascular calcification (HP:0011915) | 2.11776588 |
| 87 | Malnutrition (HP:0004395) | 2.11303477 |
| 88 | Gingival bleeding (HP:0000225) | 2.11232185 |
| 89 | Hypophosphatemic rickets (HP:0004912) | 2.08806719 |
| 90 | Menorrhagia (HP:0000132) | 2.08426088 |
| 91 | Vomiting (HP:0002013) | 2.07114066 |
| 92 | Abnormality of the gallbladder (HP:0005264) | 2.06547605 |
| 93 | Abnormality of the Achilles tendon (HP:0005109) | 2.04672077 |
| 94 | Opisthotonus (HP:0002179) | 2.01035364 |
| 95 | Reduced antithrombin III activity (HP:0001976) | 1.99585714 |
| 96 | Thrombophlebitis (HP:0004418) | 1.98999315 |
| 97 | Hemorrhage of the eye (HP:0011885) | 1.97295027 |
| 98 | Poikilocytosis (HP:0004447) | 1.96739697 |
| 99 | Increased serum pyruvate (HP:0003542) | 1.96181590 |
| 100 | Joint swelling (HP:0001386) | 1.94166363 |
| 101 | Rickets (HP:0002748) | 1.93233568 |
| 102 | Hypertriglyceridemia (HP:0002155) | 1.90936437 |
| 103 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.88938103 |
| 104 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.88938103 |
| 105 | Abnormality of vitamin metabolism (HP:0100508) | 1.88159739 |
| 106 | Renal cortical cysts (HP:0000803) | 1.88060028 |
| 107 | Abnormal cartilage morphology (HP:0002763) | 1.85227869 |
| 108 | Abnormality of iron homeostasis (HP:0011031) | 1.83609632 |
| 109 | Pulmonary embolism (HP:0002204) | 1.83157882 |
| 110 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83033230 |
| 111 | Proximal tubulopathy (HP:0000114) | 1.82672684 |
| 112 | Hydroxyprolinuria (HP:0003080) | 1.82434380 |
| 113 | Abnormality of proline metabolism (HP:0010907) | 1.82434380 |
| 114 | Elevated hepatic transaminases (HP:0002910) | 1.79037716 |
| 115 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.78645414 |
| 116 | Abnormality of glycolysis (HP:0004366) | 1.78142639 |
| 117 | Abnormal urine phosphate concentration (HP:0012599) | 1.76774064 |
| 118 | Insulin resistance (HP:0000855) | 1.76545348 |
| 119 | Fair hair (HP:0002286) | 1.76047548 |
| 120 | Facial shape deformation (HP:0011334) | 1.71471736 |
| 121 | Potter facies (HP:0002009) | 1.71471736 |
| 122 | Abnormal delivery (HP:0001787) | 1.70941762 |
| 123 | Bifid scrotum (HP:0000048) | 1.65145809 |
| 124 | Elevated alkaline phosphatase (HP:0003155) | 1.61599018 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.87783146 |
| 2 | ERN1 | 4.58701636 |
| 3 | FGFR4 | 4.31553042 |
| 4 | SIK1 | 4.30452417 |
| 5 | INSRR | 3.50792564 |
| 6 | TAOK3 | 3.23005996 |
| 7 | PDK2 | 2.95921811 |
| 8 | MAPK15 | 2.87245745 |
| 9 | ERBB4 | 2.65504716 |
| 10 | PIK3CG | 2.58214331 |
| 11 | NTRK3 | 2.53217688 |
| 12 | WNK3 | 2.20442308 |
| 13 | MAP2K4 | 2.06338153 |
| 14 | MST1R | 1.99412944 |
| 15 | FLT3 | 1.97103326 |
| 16 | PKN2 | 1.94406311 |
| 17 | TRIB3 | 1.93974660 |
| 18 | FRK | 1.93175270 |
| 19 | MAPK11 | 1.74477968 |
| 20 | NLK | 1.63801079 |
| 21 | PTK6 | 1.52312265 |
| 22 | PIK3CA | 1.45389425 |
| 23 | DAPK2 | 1.44815839 |
| 24 | LATS1 | 1.43533847 |
| 25 | PASK | 1.38918258 |
| 26 | NEK9 | 1.38165183 |
| 27 | TYK2 | 1.37719123 |
| 28 | MAP3K12 | 1.35366442 |
| 29 | MYLK | 1.29539468 |
| 30 | ABL2 | 1.25847759 |
| 31 | KDR | 1.15910264 |
| 32 | CAMKK2 | 1.13998005 |
| 33 | JAK2 | 1.11056597 |
| 34 | SCYL2 | 1.07133221 |
| 35 | PINK1 | 1.05555358 |
| 36 | PRKAA2 | 1.04930338 |
| 37 | DDR2 | 1.02008061 |
| 38 | DYRK1B | 1.00709733 |
| 39 | PRKG1 | 0.98697320 |
| 40 | LMTK2 | 0.96774872 |
| 41 | ACVR1B | 0.95737688 |
| 42 | FGFR2 | 0.94832138 |
| 43 | MAP3K3 | 0.93193331 |
| 44 | MAP3K7 | 0.91645761 |
| 45 | STK38L | 0.90676321 |
| 46 | MET | 0.89176693 |
| 47 | EPHA3 | 0.88046696 |
| 48 | MAP2K3 | 0.86877472 |
| 49 | JAK1 | 0.86783487 |
| 50 | TBK1 | 0.85752514 |
| 51 | ERBB2 | 0.84847230 |
| 52 | GRK6 | 0.84799141 |
| 53 | MAPKAPK3 | 0.84555166 |
| 54 | CAMK1D | 0.81640171 |
| 55 | MAP3K11 | 0.81171417 |
| 56 | MAP3K10 | 0.80819472 |
| 57 | MAPK4 | 0.80763183 |
| 58 | PRKCZ | 0.80009358 |
| 59 | CSK | 0.78528720 |
| 60 | PTK2 | 0.76386677 |
| 61 | EPHB1 | 0.75750960 |
| 62 | PRKACG | 0.73621857 |
| 63 | PRKACB | 0.72946193 |
| 64 | CDK6 | 0.71788427 |
| 65 | TIE1 | 0.69519089 |
| 66 | PRKACA | 0.69308737 |
| 67 | GSK3A | 0.67978879 |
| 68 | IRAK3 | 0.67054960 |
| 69 | MAP3K14 | 0.64829051 |
| 70 | RIPK1 | 0.63956997 |
| 71 | PRKAA1 | 0.62977612 |
| 72 | CAMK2G | 0.62788340 |
| 73 | HIPK2 | 0.60984252 |
| 74 | CSNK1D | 0.60889637 |
| 75 | SGK1 | 0.57908094 |
| 76 | CSNK1E | 0.57835702 |
| 77 | MAP3K1 | 0.57038126 |
| 78 | MAP2K1 | 0.56624462 |
| 79 | PRKCE | 0.55553213 |
| 80 | MAPK12 | 0.55409391 |
| 81 | STK38 | 0.55044897 |
| 82 | RPS6KA3 | 0.54597010 |
| 83 | MAP2K6 | 0.54136976 |
| 84 | MAP3K2 | 0.52932437 |
| 85 | TRPM7 | 0.52249249 |
| 86 | MUSK | 0.50948649 |
| 87 | SGK3 | 0.50696685 |
| 88 | PDPK1 | 0.49080071 |
| 89 | TGFBR2 | 0.48755343 |
| 90 | MAPK7 | 0.48333130 |
| 91 | FGFR1 | 0.47821679 |
| 92 | PAK3 | 0.46214504 |
| 93 | AKT2 | 0.44540564 |
| 94 | MTOR | 0.44219981 |
| 95 | CAMK2D | 0.44024648 |
| 96 | LATS2 | 0.43592011 |
| 97 | FGFR3 | 0.43280618 |
| 98 | MAP2K2 | 0.43237579 |
| 99 | PRKCB | 0.42949661 |
| 100 | EPHA4 | 0.41760443 |
| 101 | IGF1R | 0.41587261 |
| 102 | MAP3K13 | 0.41168093 |
| 103 | CSNK1G1 | 0.41132643 |
| 104 | RET | 0.40581389 |
| 105 | CAMK1 | 0.40431983 |
| 106 | SRC | 0.37707076 |
| 107 | SGK2 | 0.37689630 |
| 108 | MAPK3 | 0.37281799 |
| 109 | MAP3K5 | 0.36791156 |
| 110 | PRKCQ | 0.36414938 |
| 111 | PRKCG | 0.35167541 |
| 112 | GRK1 | 0.34241204 |
| 113 | IRAK1 | 0.32041073 |
| 114 | IKBKE | 0.31489206 |
| 115 | SGK223 | 0.30988753 |
| 116 | SGK494 | 0.30988753 |
| 117 | CAMK1G | 0.30262407 |
| 118 | TAOK2 | 0.30000916 |
| 119 | EPHA2 | 0.29787679 |
| 120 | AKT3 | 0.29323334 |
| 121 | CDK4 | 0.28255254 |
| 122 | PDGFRA | 0.25793841 |
| 123 | EGFR | 0.25686855 |
| 124 | CSF1R | 0.25535137 |
| 125 | PDK1 | 0.25056432 |
| 126 | KSR2 | 0.25043204 |
| 127 | WNK4 | 0.24529555 |
| 128 | PRKCA | 0.24098383 |
| 129 | MAP3K6 | 0.23524681 |
| 130 | CAMK4 | 0.20748421 |
| 131 | ICK | 0.20515655 |
| 132 | FER | 0.18888537 |
| 133 | CSNK1G2 | 0.18629949 |
| 134 | STK16 | 0.18457138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.45438455 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.53513929 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.32406118 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.29364278 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.04587589 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.76232250 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69524014 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.65051493 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62990406 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.52897276 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.52576591 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.42041161 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.20479924 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14907056 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.10417276 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.08771086 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.93550024 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.91306417 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.90477196 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.89587809 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.88097819 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.86374819 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.83924578 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.75200504 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.74439816 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.71030004 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70814728 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.69265703 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.65170115 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60316213 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.59044146 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.58925861 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.58189623 |
| 34 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.54027758 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.53654326 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.50259412 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.46929352 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.46283197 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.44320832 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.39328497 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.34118283 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.32459338 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29391746 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27027835 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.24655974 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.21266682 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18175314 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.14389336 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13300908 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00012849 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99859581 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96498624 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94001364 |
| 54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93241139 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.88232495 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83703612 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.82151443 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82149159 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81389361 |
| 60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69834530 |
| 61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69666997 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68931884 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64245208 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58628480 |
| 65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.57148882 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50037521 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49996252 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46809487 |
| 69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.44029989 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.41255766 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31896288 |
| 72 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30089799 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28363512 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26993906 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.25419111 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22023492 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19118654 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18513400 |
| 79 | Mineral absorption_Homo sapiens_hsa04978 | 0.17440796 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.17256243 |
| 81 | Pertussis_Homo sapiens_hsa05133 | 0.15448406 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.06317423 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.05610777 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04910295 |
| 85 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2197587 |
| 86 | Lysosome_Homo sapiens_hsa04142 | -0.2057329 |
| 87 | Hepatitis C_Homo sapiens_hsa05160 | -0.1938274 |
| 88 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1913196 |
| 89 | Protein export_Homo sapiens_hsa03060 | -0.1895668 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1872518 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1801862 |
| 92 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1776296 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1727346 |
| 94 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1640787 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1522849 |
| 96 | Insulin secretion_Homo sapiens_hsa04911 | -0.1373514 |
| 97 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1366308 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1253761 |
| 99 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1093302 |
| 100 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.1018926 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0720219 |
| 102 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0678316 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0660728 |
| 104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0640487 |
| 105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0546764 |
| 106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0541490 |
| 107 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0278021 |
| 108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0096814 |
| 109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0095529 |

